000			01118nam a2200121Ia 4500
008			220620s9999||||xx |||||||||||||| ||und||
245		0	_aPharmacogenomics and Personalized Medicine
546			_aEnglish[eng]
650			_aCYP2C9||VKORC1||warfarin||warfarin initiation phase of therapy||INR||pharmacogenetics study||pharmacogenomics||pharmacogenetics||genotype||phenotype||alleles||precision medicine||pharmacotranscriptomics||high-throughput analysis||childhood acute lymphoblastic leukemia||clopidogrel||acenocoumarol||CDSS||implementation||azathioprine||inflammatory bowel disease||glutathione-S transferase||pharmacokinetics||nucleoside analogs||microRNAs||gene expression||drug resistance||AML||cisplatin||nephrotoxicity||kidney injury||genetic polymorphisms||pre-emptive||panel||breast cancer subtype||miRNA||pathway||crosstalk network||precision drugs||ovarian cancer||platinum resistance||focal copy number alterations||whole exome sequencing||personalized medicine||human genetics||pharmacology
700			_aCecchin, Erika||Stocco, Gabriele
856			_uhttps://mdpi.com/books/pdfview/book/2700
942			_cEB
999			_c30430 _d30430